The GibsonGroup, in collaboration with Dr Tom Whale, have published in the Journal of the American Chemical Society, showing that polymer nanoparticles can inhibit ice growth.

read more

The particles were prepared using polymerization-induced self-assembly, which is a synthetically scalable method to obtain well-defined nanoparticles. These particles could stop ice recrystallisation and in some cases appeared to bind the ice faces, opening new opportunities to mimic the complex function of ice binding proteins, which have huge biotechnological potential. //

In November 2018, the Monash Warwick Alliance funded Chemists to develop and identify cost-effective, highly active, selective and stable catalysts. Check their progress...

The GibsonGroup, in collaboration with Dr Tom Whale, have published in the Journal of the American Chemical Society, showing that polymer nanoparticles can inhibit ice growth. Read more...

Researchers at the Universities of Warwick and Nottingham have received EPSRC funding to launch a ground-breaking research programme for global specialist chemical manufacturer, Lubrizol.

Ingrained prejudices and a lack of action addressing discrimination are some of the main reasons why academic chemistry is overwhelmingly white...

The University of Warwick spin-out company, CryoLogyx, has received a further investment from Oxford Technology Management and private investors, alongside £300k from InnovateUK.

When biological material is frozen, cryoprotectants are used to prevent ice damage. How do newly emerging polymeric cryoprotectants control ice formation and growth during freezing?

Today we are choosing to seek out and celebrate women's achievements at Warwick Chemistry.

Scientists able to see how potential cancer treatment reacts in single cell

The discovery of how hormone-like molecules turn on antibiotic production in soil bacteria could unlock the untapped opportunities for medicines that are under our very feet.

An international team of scientists working in the Department of Chemistry, the School of Life Sciences and the Warwick Integrative Synthetic Biology Centre at the University of Warwick, UK, and Monash University, Australia, have determined the molecular basis of a biological mechanism that could enable more efficient and cost-effective production of existing antibiotics, and also allow scientists to uncover new antibiotics in soil bacteria.

It is detailed in a new study published in the journal Nature.

A new biotechnology company, CryoLogyx, has been spun-out from the department, supported from a grant from InnovateUK. Cryologyx will be led by Dr Tom Congdon (A UoW UG and PG alumus) and will exploit technology developed by the GibsonGroup. Cryologyx will use innovative macromolecular (polymeric) cryoprotectants to protect biological samples, including cells used in therapy, diagnostics and drug discovery.

Read the news story here and more details will be released soon.

BonLab and VignoliniLab innovate in light scattering particles

BonLab fabricates textured microcapsules through crystallization